Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation

Williams, 2012, After Xigris, researchers look to new targets to combat sepsis, Nat. Med., 18, 1001, 10.1038/nm0712-1001 Shen, 2006, Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed, Am. J. Physiol. Gastrointest. Liver Physiol., 290, G577, 10.1152/ajpgi.00439.2005 Macintire, 2002, Bacterial translocation: clinical implications and prevention, Vet. Clin. North Am. Small Anim. Pract., 32, 1165, 10.1016/S0195-5616(02)00037-2 Gatt, 2007, Review article: bacterial translocation in the critically ill–evidence and methods of prevention, Aliment. Pharmacol. Ther., 25, 741, 10.1111/j.1365-2036.2006.03174.x Li, 2009, Disruption of tight junctions during polymicrobial sepsis in vivo, J. Pathol., 218, 210, 10.1002/path.2525 Puleo, 2011, Gut failure in the ICU, Semin. Respir. Crit. Care Med., 32, 626, 10.1055/s-0031-1287871 Papoff, 2012, Gut microbial translocation in critically ill children and effects of supplementation with pre- and pro biotics, Int. J. Microbiol., 2012, 151393, 10.1155/2012/151393 Vandenbroucke, 2013, Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF, EMBO Mol. Med., 5, 932, 10.1002/emmm.201202100 Ayabe, 2000, Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria, Nat. Immunol., 1, 113, 10.1038/77783 Andersson, 2012, CRS-peptides: unique defense peptides of mouse Paneth cells, Mucosal Immunol., 5, 367, 10.1038/mi.2012.22 Hornef, 2004, Increased diversity of intestinal antimicrobial peptides by covalent dimer formation, Nat. Immunol., 5, 836, 10.1038/ni1094 Ouellette, 2001, Paneth cell defensins and innate immunity of the small bowel, Inflamm. Bowel Dis., 7, 43, 10.1097/00054725-200102000-00007 Vanlaere, 2009, Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock, Clin. Microbiol. Rev., 22, 224, 10.1128/CMR.00047-08 Vandenbroucke, 2011, A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?, Eur. Respir. J., 38, 1200, 10.1183/09031936.00027411 Dejonckheere, 2011, Matrix metalloproteinases as drug targets in ischemia/reperfusion injury, Drug Discov. Today, 16, 762 Vandenbroucke, 2012, Matrix Metalloprotease 8-Dependent Extracellular Matrix Cleavage at the Blood-CSF Barrier Contributes to Lethality during Systemic Inflammatory Diseases, J. Neurosci., 32, 9805, 10.1523/JNEUROSCI.0967-12.2012 Wilson, 1999, Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense, Science, 286, 113, 10.1126/science.286.5437.113 Pal, 2006, Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection, Immunology, 117, 213, 10.1111/j.1365-2567.2005.02281.x Swee, 2008, Matrix metalloproteinase-7 (matrilysin) controls neutrophil egress by generating chemokine gradients, J. Leukoc. Biol., 83, 1404, 10.1189/jlb.0108016 Zuo, 2002, Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans, Proc. Natl. Acad. Sci. USA, 99, 6292, 10.1073/pnas.092134099 Shi, 2007, A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion, J. Immunol., 179, 1245, 10.4049/jimmunol.179.2.1245 Cantaluppi, 2008, Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors, Intensive Care Med., 34, 1638, 10.1007/s00134-008-1124-6 Cruz, 2009, Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial, JAMA, 301, 2445, 10.1001/jama.2009.856 Cruz, 2007, Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review, Crit. Care, 11, R47, 10.1186/cc5780 Wang, 2008, Therapeutic potential of HMGB1-targeting agents in sepsis, Expert Rev. Mol. Med., 10, e32, 10.1017/S1462399408000884 Tucker, 1977, Changes in human hexosaminidase isoenzyme distribution in body fluids during the course of tissue damage, Biochem. Soc. Trans., 5, 241, 10.1042/bst0050241 Ayabe, 2002, Activation of Paneth cell alpha-defensins in mouse small intestine, J. Biol. Chem., 277, 5219, 10.1074/jbc.M109410200 Rumio, 2012, Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands, J. Cell Physiol., 227, 1107, 10.1002/jcp.22830 Lopez-Boado, 2000, Bacterial exposure induces and activates matrilysin in mucosal epithelial cells, J. Cell Biol., 148, 1305, 10.1083/jcb.148.6.1305 Berlanga, 2002, Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage, Am. J. Pathol., 161, 373, 10.1016/S0002-9440(10)64192-2 Berlanga, 2002, Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents, Burns, 28, 435, 10.1016/S0305-4179(02)00023-2 Liu, 1997, The effect of epidermal growth factor on the septic complications of acute pancreatitis, J. Surg. Res., 69, 171, 10.1006/jsre.1997.5069 Clark, 2009, Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis, Am. J. Physiol. Gastrointest. Liver Physiol., 297, G471, 10.1152/ajpgi.00012.2009 Clark, 2008, Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis, Shock, 30, 36 Dominguez, 2011, Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumonia, Shock, 36, 381, 10.1097/SHK.0b013e31822793c4 Dvorak, 2002, Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G156, 10.1152/ajpgi.00196.2001 Fink, 2003, Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness, Curr. Opin. Crit. Care, 9, 143, 10.1097/00075198-200304000-00011 Salzman, 2010, Enteric defensins are essential regulators of intestinal microbial ecology, Nat Immunol, 11, 76, 10.1038/ni.1825 Turner, 2009, Intestinal mucosal barrier function in health and disease, Nat. Rev. Immunol., 9, 799, 10.1038/nri2653 John, 2011, Epithelial barriers in intestinal inflammation, Antioxid. Redox Signal, 15, 1255, 10.1089/ars.2011.3892 Noth, 2012, Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn's disease, J. Crohns Colitis, 6, 464, 10.1016/j.crohns.2011.10.004 Marchiando, 2010, Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo, J. Cell Biol., 189, 111, 10.1083/jcb.200902153 Park, 2012, Paneth cell-mediated multiorgan dysfunction after acute kidney injury, J. Immunol., 189, 5421, 10.4049/jimmunol.1200581 Takahashi, 2008, IL-17 produced by Paneth cells drives TNF-induced shock, J. Exp. Med., 205, 1755, 10.1084/jem.20080588 Ilan, 2012, Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis, World J. Gastroenterol., 18, 2609, 10.3748/wjg.v18.i21.2609 Faries, 1998, Intestinal permeability correlates with severity of injury in trauma patients, J. Trauma, 44, 1031, 10.1097/00005373-199806000-00016 Swank, 1996, Role of the gut in multiple organ failure: bacterial translocation and permeability changes, World J. Surg., 20, 411, 10.1007/s002689900065 Vandenbroucke, 2013, Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF, EMBO Mol. Med., 5, 1000, 10.1002/emmm.201202100 Van Hauwermeiren, 2013, Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium, J. Clin. Invest., 123, 2590, 10.1172/JCI65624 Mastroianni, 2012, Alternative luminal activation mechanisms for paneth cell alpha-defensins, J. Biol. Chem., 287, 11205, 10.1074/jbc.M111.333559 Noble, 2008, Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis, Gut, 57, 1398, 10.1136/gut.2008.148395 Rath, 2006, Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?, Inflamm. Bowel Dis., 12, 1025, 10.1097/01.mib.0000234133.97594.04 Rath, 2010, Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis, Scand. J. Gastroenterol., 45, 1186, 10.3109/00365521.2010.499961 Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol., 3, 10.1186/gb-2002-3-7-research0034